THE ACCURACY OF DRUG INFORMATION FROM PHARMACEUTICAL SALES REPRESENTATIVES

被引:184
|
作者
ZIEGLER, MG [1 ]
LEW, P [1 ]
SINGER, BC [1 ]
机构
[1] UNIV CALIF SAN DIEGO,SCH MED,DEPT PHARM,SAN DIEGO,CA 92103
来源
关键词
D O I
10.1001/jama.273.16.1296
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective.-To provide quantitative data about the accuracy of the information about drugs presented to physicians by pharmaceutical sales representatives. Design.-One hundred six statements about drugs made during 13 presentations by pharmaceutical representatives were analyzed for accuracy. Statements were rated inaccurate if they contradicted the 1993 Physicians' Desk Reference or material quoted or handed out by the sales representative. Setting.-University teaching hospital. Results.-Twelve (11%) of 106 statements about drugs were inaccurate. All 12 inaccurate statements were favorable toward the promoted drug, whereas 39 (49%) of 79 accurate statements were favorable (P=.005). None of 15 statements about competitors' drugs were favorable, but all were accurate, significantly (P<.001) differing from statements about promoted drugs. In a survey of 27 physicians who attended these presentations, seven (26%) recalled any false statement made by a pharmaceutical representative, and 10 (37%) said information from the representatives influenced the way they prescribed drugs. Conclusions.-Eleven percent of the statements made by pharmaceutical representatives about drugs contradicted information readily available to them. Physicians generally failed to recognize the inaccurate statements.
引用
收藏
页码:1296 / 1298
页数:3
相关论文
共 50 条
  • [11] Physicians, pharmaceutical sales representatives, and the cost of prescribing
    Caudill, TS
    Johnson, MS
    Rich, EC
    McKinney, WP
    [J]. ARCHIVES OF FAMILY MEDICINE, 1996, 5 (04) : 201 - 206
  • [12] Pharmaceutical Sales Representatives and Patient Safety Reply
    Mintzes, Barbara
    Lexchin, Joel
    Wilkes, Michael S.
    Beaulieu, Marie-Dominique
    Reynolds, Ellen
    Sutherland, Jason
    Durrieu, Genevieve
    [J]. JOURNAL OF GENERAL INTERNAL MEDICINE, 2013, 28 (11) : 1395 - 1395
  • [13] PHYSICIAN ATTITUDES TOWARD PHARMACEUTICAL SALES REPRESENTATIVES
    ANDALEEB, SS
    TALLMAN, RF
    [J]. HEALTH CARE MANAGEMENT REVIEW, 1995, 20 (03) : 68 - 76
  • [14] INFLUENCE OF PHARMACEUTICAL SALES REPRESENTATIVES ON THE FORMULARY SYSTEM
    HOPPE, SA
    GORAHARPER, ML
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1995, 52 (14) : 1549 - 1551
  • [15] Utilization of Drug Information Systems by Medical Representatives in the Japanese Pharmaceutical Industry
    Manai Yamamoto
    Tomoko Iizuka
    Hisako Negi
    Mayumi Shimizu
    Shoichi Funabashi
    Seizaburo Okada
    [J]. Drug information journal : DIJ / Drug Information Association, 1998, 32 (3): : 761 - 767
  • [16] Physicians and drug company sales representatives
    Davis, GF
    [J]. AMERICAN JOURNAL OF MEDICINE, 2000, 108 (05): : 432 - 432
  • [17] DRUG COMPANY REPRESENTATIVES AND SALES PRIORITIES
    COLLIER, J
    [J]. LANCET, 1993, 341 (8851): : 1031 - 1032
  • [18] Utilization of drug information systems by medical representatives in the Japanese pharmaceutical industry
    Yamamoto, M
    Iizuka, T
    Negi, H
    Shimizu, M
    Funabashi, S
    Okada, S
    [J]. DRUG INFORMATION JOURNAL, 1998, 32 (03): : 761 - 767
  • [19] DRUG COMPANY REPRESENTATIVES AND SALES PRIORITIES
    WEAVING, PG
    [J]. LANCET, 1993, 341 (8857): : 1416 - 1416
  • [20] Nurse prescribers' interactions with and perceptions of pharmaceutical sales representatives
    Clauson, Kevin A.
    Khanfar, Nile M.
    Polen, Hyla H.
    Gibson, Florencetta
    [J]. JOURNAL OF CLINICAL NURSING, 2009, 18 (02) : 228 - 233